Gottlieb Outlines FDA Plans for Compounding Enforcement

In Jan. 30 testimony before a House subcommittee, FDA Commissioner Scott Gottlieb told lawmakers the FDA’s plans for regulating compounding pharmacies, including adapting GMP and oversight standards to a facility’s level of risk.
Source: Drug GMP Report